Multi-Active Topical Composition for Once-Daily Acne and Photoaging Treatment

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current dermatological treatments for acne and photoaging often require multiple products applied at different times of day due to ingredient incompatibilities and interactions, lacking a stable, once-daily composition that can effectively treat both conditions simultaneously.

Innovation Solution

A composition comprising three distinct anti-acne and anti-photoaging compounds - azelaic acid, clindamycin, niacinamide, and ascorbyl phosphate - formulated in a single topical application to address acne and photoaging concurrently.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If multiple separate dermatological products are used to treat acne and photoaging, then treatment effectiveness is maintained, but patient convenience and adherence deteriorate due to multiple applications at different times

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidpatient convenience
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The patent combines multiple anti-acne compounds (benzoyl peroxide, salicylic acid, resorcinol) and anti-photoaging compounds (retinol, alpha hydroxy acids, beta hydroxy acids) into a single topical composition that can be applied once daily, eliminating the need for multiple separate products and applications at different times of day

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The single composition serves multiple functions simultaneously: it treats acne through comedolytic and antimicrobial mechanisms while also preventing and treating photoaging through antioxidant and cell turnover enhancement, allowing one product to replace multiple specialized treatments

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Ease of operation

If a single combined formulation is created to treat both acne and photoaging, then patient convenience improves, but formulation stability and ingredient compatibility deteriorate due to ingredient interactions

Engineering Contradiction:
Improvepatient convenienceVSAvoidformulation stability
Core Design Contradiction:
Ease of operationVSStability of the object's composition

Solution Approach 1:

The patent employs a carefully selected vehicle system and pH buffering agents that act as intermediaries to maintain compatibility between otherwise incompatible ingredients, preventing degradation and unwanted interactions while allowing all active compounds to coexist in a stable single formulation

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The formulation utilizes controlled pH adjustment and concentration optimization to ensure ingredient stability, maintaining the composition within a pH range that prevents degradation of acid-sensitive compounds while preserving the efficacy of all anti-acne and anti-photoaging agents

Inventive Principle:
Principle #35Parameter changes

3Device complexity

If anti-acne ingredients are combined in a single formulation, then treatment simplicity improves, but ingredient inactivation occurs due to chemical interactions between compounds

Engineering Contradiction:
Improvetreatment simplicityVSAvoidingredient efficacy
Core Design Contradiction:
Device complexityVSReliability

Solution Approach 1:

The formulation employs localized stabilization strategies where specific chelating agents and antioxidants are positioned to protect particular sensitive ingredients from degradation, creating micro-environments within the formulation that preserve the activity of each active compound despite their proximity to potentially incompatible substances

Inventive Principle:
Principle #3Local quality

Data Source

PatentUS12350282B2Compositions and methods of treating acne and photoaging
Publication Date: 2025.07.08 CUROLOGY INC
  • US12350282B2 patent drawing

AI summary

Pharmaceutical compositions comprising a first anti-acne compound, a second anti-acne compound, and an anti-photoaging compound are described. Methods for the treatment of acne and photoaging using the compositions are also described.